Lexicon Pharmaceuticals Inc (LXRX)
1.695
-0.02
(-0.88%)
USD |
NASDAQ |
Apr 23, 10:42
Lexicon Pharmaceuticals Total Assets (Quarterly): 229.43M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 229.43M |
| September 30, 2023 | 276.48M |
| June 30, 2023 | 316.72M |
| March 31, 2023 | 162.72M |
| December 31, 2022 | 194.30M |
| September 30, 2022 | 191.68M |
| June 30, 2022 | 112.32M |
| March 31, 2022 | 136.18M |
| December 31, 2021 | 136.91M |
| September 30, 2021 | 172.33M |
| June 30, 2021 | 171.67M |
| March 31, 2021 | 193.26M |
| December 31, 2020 | 203.79M |
| September 30, 2020 | 178.93M |
| June 30, 2020 | 322.54M |
| March 31, 2020 | 370.57M |
| December 31, 2019 | 417.72M |
| September 30, 2019 | 444.59M |
| June 30, 2019 | 233.14M |
| March 31, 2019 | 258.52M |
| December 31, 2018 | 284.14M |
| September 30, 2018 | 310.19M |
| June 30, 2018 | 332.94M |
| March 31, 2018 | 386.81M |
| December 31, 2017 | 436.54M |
| Date | Value |
|---|---|
| September 30, 2017 | 329.49M |
| June 30, 2017 | 363.51M |
| March 31, 2017 | 396.26M |
| December 31, 2016 | 475.62M |
| September 30, 2016 | 516.94M |
| June 30, 2016 | 558.13M |
| March 31, 2016 | 611.34M |
| December 31, 2015 | 651.96M |
| September 30, 2015 | 391.14M |
| June 30, 2015 | 415.96M |
| March 31, 2015 | 444.68M |
| December 31, 2014 | 471.38M |
| September 30, 2014 | 187.52M |
| June 30, 2014 | 224.06M |
| March 31, 2014 | 243.60M |
| December 31, 2013 | 274.16M |
| September 30, 2013 | 299.46M |
| June 30, 2013 | 323.39M |
| March 31, 2013 | 347.28M |
| December 31, 2012 | 371.78M |
| September 30, 2012 | 357.84M |
| June 30, 2012 | 381.06M |
| March 31, 2012 | 402.79M |
| December 31, 2011 | 430.51M |
| September 30, 2011 | 294.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
112.32M
Minimum
Jun 2022
444.59M
Maximum
Sep 2019
235.01M
Average
194.30M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Novavax Inc | 1.797B |
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 136.32M |
| Shareholders Equity (Quarterly) | 93.11M |
| Debt to Equity Ratio | 1.069 |
| Current Ratio | 5.596 |
| Net Debt Paydown Yield | -4.04% |